医渡科技有限公司(02158)于2025年12月4日公告，其当天在香港联交所购回公司股份，涉及数量为181,000股，占购回前已发行股份约0.017%。公司本次回购每股价格介乎5.14港元至5.15港元，总成交金额约93.16万港元。
本次回购完成后，公司已发行股份总数维持约1,070,634,831股，其中流通股约1,063,283,231股，库存股约7,351,600股。公司此前于2025年8月29日通过购回授权，授权上限为106,455,574股。截至目前，累计购回4,460,500股，约占授权通过当日已发行股份总数的0.419%。
公司在公告中确认，所有购回股份相关程序均遵守香港联交所上市规则及相关法律法规。该公告由公司董事宫盈盈签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.